Cephalalgia

Papers
(The TQCC of Cephalalgia is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-11-01 to 2025-11-01.)
ArticleCitations
Genetic characterization of the endocannabinoid system and psychiatric features in patients with migraine and medication overuse headache120
Chronic Migraine Epidemiology and Outcomes – International (CaMEO-I) Study: Methods and multi-country baseline findings for diagnosis rates and care102
Visual snow vs. migraine aura: Debate summary and novel insights into the syndrome94
Harassment in the headache field: a global web-based cross-sectional survey72
A reply, drug-induced reversible cerebral vasoconstriction syndrome: Lessons from the real world72
Efficacy and tolerability of combination treatment of topiramate and greater occipital nerve block versus topiramate monotherapy for the preventive treatment of chronic migraine: A randomized controll63
International Classification of Headache Disorders-4 – Work in Progress 149
Efficacy of different cannabinoid compounds on migraine-like responses in female rats46
Evidence-based guidelines for the pharmacological treatment of migraine40
Impact of psychiatric comorbidity, resilience and executive function on childhood and adolescent headaches: A narrative review38
Evaluating the efficacy of CGRP mAbs and gepants for the preventive treatment of migraine: A systematic review and network meta-analysis of phase 3 randomised controlled trials38
Systemic lupus erythematosus mimicking retinal migraine: a case report37
An altered reward system characterizes chronic migraine with medication overuse headache37
Rethinking migraine with aura: Why cortical spreading depolarization (depression), not aura, causes headaches36
Pain sensitivities predict prophylactic treatment outcomes of flunarizine in chronic migraine patients: A prospective study35
Corrigendum to: Evaluation of outcomes of calcitonin gene-related peptide (CGRP)-targeting therapies for acute and preventive migraine treatment based on patient sex35
Genome-wide DNA methylation analysis in an antimigraine-treated preclinical model of cortical spreading depolarization33
History of maternal migraine and its association with preeclampsia: A case–control study in a low-resource setting in Sudan, Africa33
The effects of certain TRP channels and voltage-gated KCNQ/Kv7 channel opener retigabine on calcitonin gene-related peptide release in the trigeminovascular system33
Depression screening in migraine - A double-edged sword32
Triptan non-response in a London tertiary headache centre: What can we learn? A retrospective study32
Childhood and adolescent headache: A problem not to be ignored in the era of new therapies32
Comment on “What predicts citation counts and translational impact in headache research? A machine learning analysis”31
Painful nervus intermedius neuropathy attributed to Bell's palsy: The need for independent diagnostic criteria31
Guidelines of the International Headache Society for controlled trials of pharmacological preventive treatment for persistent post-traumatic headache attributed to mild traumatic brain injury30
Paroxysmal hemicrania and hemicrania continua: Review on pathophysiology, clinical features and treatment30
Population-based prevalence of cranial autonomic symptoms in migraine and proposed diagnostic appendix criteria29
Effect of Altmetric score on manuscript citations: A randomized-controlled trial29
Diagnosis of idiopathic intracranial hypertension - the importance of excluding secondary causes: A systematic review29
Galcanezumab modulates Capsaicin-induced C-fiber reactivity28
COVID-19 vaccination-triggered cluster headache episodes with frequent attacks28
Looking at Cephalalgia from the inside27
Comorbidity or combination – more evidence for cluster-migraine?27
The non-decussating and decussating trigeminothalamic tracts in humans: A combination of connectome-based tractography and histological validation27
Author response to ‘Clarification on the incidence and sex-specificity of sexual dysfunction as an adverse event of CGRP-targeting medications’27
Long-term open-label and real-world studies of lasmiditan, ubrogepant, and rimegepant for the acute treatment of migraine attacks26
Sex differences in photophobic behaviors following cortical spreading depression in rats25
Crossing the Rubicon? The future impact of artificial intelligence on headache medicine25
What is the evolutionary disadvantage of migraine?25
Physical impairment during and between migraine attacks: A daily diary study of patients with chronic migraine23
Guidelines of the International Headache Society for Clinic-Based Headache Registries, 1st edition22
Safety profile of monoclonal antibodies targeting the calcitonin gene-related peptide system in pregnancy: Updated analysis in VigiBase®22
Migraine and risk of atrial fibrillation: A 9-year follow-up based on the Trøndelag Health Study21
Overlap between perceived triggers, premonitory symptoms and symptom persistence across migraine phases: A REFORM study20
Case reports: Could sexual dysfunction in women with migraine be a side effect of CGRP inhibition?20
Real-world efficacy of galcanezumab for the treatment of migraine in Korean patients20
Effect of COVID vaccination on monthly migraine days: a longitudinal cohort study20
Guidelines Update: Guidelines of the International Headache Society for controlled trials of preventive treatment of migraine in children and adolescents, 1st edition – An experience-based update20
Immunogenicity of erenumab: A pooled analysis of six placebo-controlled trials with long-term extensions19
Genome sequencing reveals the Adgrl3 ( ADGRL3 ) gene as a possible cause of cephalic hypersensitivity in the STA rat and migraine in human19
A placebo-controlled, randomized, single and multiple dose study to evaluate the safety, tolerability, and pharmacokinetics of rimegepant in healthy participants19
The midfacial segment pain: little known disorder in need of scientific evaluation19
Neck pain in migraine: A narrative review and steps to correct evaluation and treatment19
Abstracts from the International Headache Congress 14–17 September 202318
Sensitivity of the SNNOOP10 list in the high-risk secondary headache detection18
Involvement of adenosine signaling pathway in migraine pathophysiology: A systematic review of clinical studies18
Burden of headache in a HIV-positive population of sub-Saharan Africa18
Psychophysical testing in chronic migraine and chronic tension type headache: An observational study18
Advancing understanding of migraine pathophysiology and therapy by consideration of patient sex18
Thanks to Reviewers18
Preclinical and clinical evaluation of LY3451838, a PACAP-neutralizing monoclonal antibody, in randomized, double-blind, placebo-controlled phase 1 and phase 2 studies involving healthy adults and adu18
Worldwide availability of medications for migraine and tension-type headache: A survey of the International Headache Society17
Muscae volitantes: A 19th-century precursor of visual snow syndrome?17
Abnormal heart rate variability and its application in predicting treatment efficacy in patients with chronic migraine: An exploratory study17
Alopecia as an emerging adverse event to CGRP monoclonal antibodies: Cases Series, evaluation of FAERS, and literature review17
The “index vein” as a sign for migraine aura in the emergency setting17
Migraine-attributed burden, impact and disability, and migraine-impacted quality of life: Expert consensus on definitions from a Delphi process17
Plasma adrenomedullin levels in migraine: A registry for migraine (REFORM) study17
Stroke due to small-vessel disease and migraine: A case–control study of a young adult with ischemic stroke population16
Exploring the association between familial hemiplegic migraine genes (CACNA1A, ATP1A2 and SCN1A) with migraine and epilepsy: A UK Biobank exome-wide association study16
Guidelines of the International Headache Society for Controlled Clinical Trials in Cluster Headache16
Letter to the Editor regarding “Effect of Altmetric score on manuscript citations: A randomized-controlled trial”16
Internet and social media's role in migraine education: Headache or not headache?16
Neurological and psychiatric comorbidities of migraine: Concepts and future perspectives16
Two-year, real-world erenumab persistence and quality of life data in 82 pooled patients with abrupt onset, unremitting, treatment refractory headache and a migraine phenotype: New daily persistent he16
Erratum16
Corneal confocal microscopy identifies corneal nerve fiber loss in patients with migraine15
Shared genetics and causal relationships between migraine and thyroid function traits15
Efficacy and safety of monoclonal antibodies targeting CGRP in migraine prevention. GRADE tables elaborated by the ad hoc working group of the International Headache Society15
Brain imaging in migraine with and without aura: Similarities and differences15
The effect of treatment onset time on acute efficacy in migraine patients treating with remote electrical neuromodulation (REN)15
Are we closer to achieving precision medicine for migraine treatment? A narrative review15
Efficacy of eptinezumab in non-responders to subcutaneous monoclonal antibodies against CGRP and the CGRP receptor: A retrospective cohort study15
Comorbidity with fibromyalgia predicted poorer outcomes in patients with chronic migraine on flunarizine: Prospective proof-of-concept study15
Effectiveness of anti-CGRP monoclonal antibodies and onabotulinumtoxinA in menstrually-related migraine: The unmet need of perimenstrual headache days15
The impact of eating disorders on idiopathic intracranial hypertension15
Post-COVID-19 persistent headache: A multicentric 9-months follow-up study of 905 patients15
Premonitory symptoms in migraine: A REFORM Study14
Switching anti-CGRP(R) monoclonal antibodies in multi-assessed non-responder patients and implications for ineffectiveness criteria: A retrospective cohort study14
New migraine drugs: A critical appraisal of the reason why the majority of migraine patients do not receive an adequate medication14
Are the ICHD-3 criteria for headache attributed to idiopathic intracranial hypertension valid? Headache phenotyping and field-testing in newly diagnosed idiopathic intracranial hypertension14
Corrigendum: No structural brain alterations in new daily persistent headache – a cross sectional VBM/SBM study14
Reply to “Methodological considerations in assessing the impact of CGRP monoclonal antibodies on blood pressure”14
Board Walk – April 202214
Avoidance behaviour modulates but does not condition phonophobia in migraine14
The long-term effect of work schedule, shift work disorder, insomnia and restless legs syndrome on headache among nurses: A prospective longitudinal cohort study13
“Wearing-off” efficacy of CGRP monoclonal antibodies for migraine prevention: A meta-analysis of randomized controlled trials13
Comment on “Lack of reproducibility of resting-state functional MRI findings in migraine with aura”13
Prevalence of neck pain in migraine: A systematic review and meta-analysis13
Cigarette smoking history (personal and secondary childhood exposure) in non-cluster headache trigeminal autonomic cephalalgias: A clinic based study13
Comparison of continuous headache features in youth with migraine, new daily persistent headache, and persistent post-traumatic headache13
Bridging the gaps of headache care for underserved populations: Current status of the headache field in Latin America13
Hypnic Headache – What do we know in 2022?13
Recurrent Painful Ophthalmoplegic Neuropathy: A case report with atypical features and a review of the literature13
Longitudinal trajectories of posttraumatic headache after pediatric mild traumatic brain injury13
Children under 6 years with acute headache in Pediatric Emergency Departments. A 2-year retrospective exploratory multicenter Italian study13
Headache at the chronic stage of cerebral venous thrombosis13
Electrophysiological findings in migraine may reflect abnormal synaptic plasticity mechanisms: A narrative review13
Prevalence and treatment of typical and atypical headaches in patients with Chiari I malformation: A meta-analysis and literature review12
Proposed general diagnostic criteria for secondary headaches12
Timing of headache after COVID-19 vaccines and its association with cerebrovascular events: An analysis of 41,700 VAERS reports12
Cephalalgia: a legacy of excellence, a vision for tomorrow12
Hypersensitivity to CGRP as a predictive biomarker of migraine prevention with erenumab12
Efficacy and safety of eptinezumab in a predominantly Asian population with chronic migraine: Results of the randomized, double-blind, placebo-controlled SUNRISE trial12
Opening of ATP-sensitive potassium channels activates meningeal nociceptors: Implications for the origin of migraine headache12
Generative chatbots in headache education and research: A narrative review12
Orofacial pain for clinicians: A review of constant and attack-like facial pain syndromes12
The clinical outcome of patients starting monoclonal antibodies anti-CGRP with concomitant migraine preventive treatments12
Mutation screening and association analysis of NOTCH3 p.R544C in patients with migraine with or without aura12
Late Breaking Author Index12
Longitudinal differences in iron deposition in periaqueductal gray matter and anterior cingulate cortex are associated with response to erenumab in migraine12
Smooth muscle ATP-sensitive potassium channels mediate migraine-relevant hypersensitivity in mouse models11
Multidisciplinary headache treatment with work-focus in Norway: An observational study11
Open-label trials for CGRP-targeted drugs in migraine prevention: A narrative review11
Erenumab versus topiramate for the prevention of migraine – a randomised, double-blind, active-controlled phase 4 trial11
The psychometric properties of an e-headache diary in migraine11
Transition of headache care from childhood to adulthood: Focusing needs, barriers, and models of care. A position paper of the IHS Child and Adolescent Committee11
Research to improve headache classification: Results, methods, and future challenges11
Other primary headaches: Distinct clinical features and uncertain pathophysiology11
Oxygen inhalation has no effect on provoked cranial autonomic symptoms using kinetic oscillation stimulation in healthy volunteers11
An evolving machine-learning-based algorithm to early predict response to anti-CGRP monoclonal antibodies in patients with migraine11
It's not either-or: Why migraine care needs both real-world evidence studies and randomized controlled trials11
Adjunctive occipital nerve block for emergency treatment of acute migraine: A randomized, controlled trial11
Persistent headache attributed to past cervicocephalic artery dissection: clinical characteristics and contributors to headache persistence10
Recovery and long-term outcome after neurosurgical closure of spinal CSF leaks in patients with spontaneous intracranial hypotension10
Developing an artificial intelligence-based headache diagnostic model and its utility for non-specialists’ diagnostic accuracy10
Headache provocation by nitric oxide in men who have never experienced a headache10
Safety and tolerability of fremanezumab in patients with episodic and chronic migraine: a pooled analysis of phase 3 studies10
How migraine and its associated treatment impact on pregnancy outcomes: Umbrella review with updated systematic review and meta-analysis10
Migraine and the risk of stroke in a middle-aged and elderly population: A prospective cohort study10
Treatment experiences and clinical characteristics in migraine and tension-type headache patients before the first visit to a tertiary headache center10
Comment on ‘'Correlation between endometriosis and migraine features: Results from a prospective case-control study'‘10
A need for an expert consensus guideline on performing peripheral nerve blocks in headache patients10
Epicranial headaches part 2: Nummular headache and epicrania fugax10
Personal view: Modelling pain mechanisms of migraine without aura10
Overuse of analgesics can affect the fertility biomarker Anti-Müllerian Hormone in females. A translational study10
0.13822293281555